The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 25, 2023
Filed:
Jul. 27, 2020
Legochem Biosciences, Inc., Youseong-Gu, KR;
Abl Bio, Inc., Seongnam-Si, KR;
Yun-Hee Park, Daejeon, KR;
Ho Young Song, Daejeon, KR;
Hyun Min Ryu, Daejeon, KR;
Sung Min Kim, Daejeon, KR;
Ju Yuel Baek, Daejeon, KR;
Ji Hye Oh, Daejeon, KR;
Nara Han, Daejeon, KR;
Hyoung Rae Kim, Daejeon, KR;
Kyung Eun Park, Daejeon, KR;
Hyeun Joung Lee, Daejeon, KR;
Ju Young Lee, Daejeon, KR;
Dae Hyuck Kang, Daejeon, KR;
Young-Jae Yang, Daejeon, KR;
Ji-Na You, Daejeon, KR;
Yong Zu Kim, Daejeon, KR;
Chang Sun Lee, Daejeon, KR;
Jeiwook Chae, Daejeon, KR;
Jinwon Jung, Daejeon, KR;
Juhee Kim, Daejeon, KR;
Bora Lee, Daejeon, KR;
Daehae Song, Daejeon, KR;
Byungje Sung, Daejeon, KR;
Donghoon Yeom, Daejeon, KR;
Jaehyun Eom, Daejeon, KR;
Youngeun Hong, Daejeon, KR;
Jinhyung Ahn, Daejeon, KR;
Yangsoon Lee, Daejeon, KR;
Kyungjin Park, Daejeon, KR;
Jiseon Yoo, Daejeon, KR;
Minji Park, Daejeon, KR;
LegoChem Biosciences, Inc., Youseong-Gu, KR;
ABL Bio, Inc., Gyeonggi-do, KR;
Abstract
The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.